Being Tactical = Mo...
Health Care: Health Services
Alcon Inc. (ACL: NYSE)
$167.99 -0.35 | -0.21%
04/08/11 - 04:00 PM ET
4.46M / 2.01M
Vol / Avg. Vol:170.16 / 168.34
Open / Prev. Close:167.35 - 170.25
Today's Range:134.44 - 170.64
52 Wk Range:2.81%
Performance YTD:TheStreet Rating:
Portfolios with ACL
- Portfolio NameUser Type
- ProMichael Price - MFP Investors
- User30 or Less
- Contributor4 Best Holdings in Harvard'...
- Contributor10 Stocks That Matter Most ...
- Contributor10 Stocks Favored by Hedge ...
- ContributorFour Stocks Liked by the Bi...
- Contributor10 Top Hedge Fund Buys
- ContributorStocks Third Point is Buyin...
- UserHelios 1
- ContributorRocket Stocks for the Week ...
Latest ACL Headlines from TheStreet
- Novartis Profit Falls 4%, Sales Rise 16% 04.19.11 | 04:04 am
- Stocks Under $10: Stealth Growth Play
04.12.11 | 12:04 pm - 4 Best Holdings in Harvard's Portfolio 03.10.11 | 09:03 am
- Nestle Profits Get Boost From Alcon Sale 02.17.11 | 04:02 am
- 5 Drug Stocks With Upside Potential of 25% 01.20.11 | 10:01 am
- 10 Stocks Favored by Hedge Funds 01.07.11 | 10:01 am
- Ryder, Novartis, Hertz, Dynegy Are Big Movers 12.15.10 | 04:12 pm
- Stock Futures Dip on Spain Rating Warning 12.15.10 | 08:12 am
- First Solar, Dynegy: Premarket Trading 12.15.10 | 08:12 am
- Novartis Buys Rest of Alcon Stake for $12.9B 12.15.10 | 03:12 am
Press Releases for ACL
- Dr. Reddy’s Announces The USFDA Approval Of Fondaparinux Sodium Injection - Business Wire 07.13.11 | 01:07 am
- Anthony Clark - Issuance Of Shares For Bonuses - Business Wire 07.11.11 | 08:07 pm
- Anthony Clark – Dismissal Of Bankruptcy Adversary Proceeding Complaint By Brooke Trustee On U.S. Subsidiaries - Business Wire 06.13.11 | 07:06 pm
- Anthony Clark Announces Sale Of Southern California Agency - Business Wire 06.08.11 | 07:06 pm
- Anthony Clark - Normal Course Issuer Bid - Business Wire 05.16.11 | 07:05 pm
- Alcon Shareholders Approve Merger With Novartis - Business Wire 04.07.11 | 04:04 pm
- Alcon Files Form 20-F With U.S. Securities And Exchange Commission - Business Wire 03.18.11 | 06:03 pm
- Alcon Announces Date Of Annual General Meeting - Business Wire 02.28.11 | 01:02 am
- Anthony Clark-Issuance Of Shares For Debt - Business Wire 02.11.11 | 12:02 pm
- Alcon Posts Solid Fourth Quarter Financial Results - Business Wire 01.27.11 | 12:01 am
Partner Headlines for ACL
- Novartis Drug Approval Delayed - Analyst Blog - Zacks 03.25.11 | 07:03 pm
- 4 Picks for the Healthcare Rebound - Seeking Alpha 03.24.11 | 09:03 am
- NVS' Lucentis Gets EU Backing - Analyst Blog - Zacks 03.23.11 | 10:03 am
- Mixed Opinion on NVS Lung Drug - Analyst Blog - Zacks 03.10.11 | 08:03 pm
- Alcon, Inc. - Growth & Income - Zacks 02.24.11 | 01:02 am
- John Paulson's 20 Largest Holdings and Recent Performance - Seeking Alpha 02.22.11 | 09:02 am
- Novartis to Buy Genoptix - Analyst Blog - Zacks 01.28.11 | 09:01 am
- Thomas Steyer's Winning Hedge Fund Holdings - Seeking Alpha 01.23.11 | 06:01 am
- A Big Week for Earnings - Seeking Alpha 01.21.11 | 05:01 pm
- 20 Underperforming Stocks With a Track Record of Profitability - Seeking Alpha 01.14.11 | 06:01 am
